164 related articles for article (PubMed ID: 25523934)
1. Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells.
Di BB; Li HW; Li WP; Shen XH; Sun ZJ; Wu X
Mol Med Rep; 2015 Apr; 11(4):2601-7. PubMed ID: 25523934
[TBL] [Abstract][Full Text] [Related]
2. Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries.
Gao S; Hua B; Liu Q; Liu H; Li W; Li H
BMC Cardiovasc Disord; 2020 Jul; 20(1):337. PubMed ID: 32664860
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
Gao H; Li H; Li W; Shen X; Di B
Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
8. Effect of pioglitazone on the calcification of rat vascular smooth muscle cells through the downregulation of the Wnt/β‑catenin signaling pathway.
Gao M; Chen T; Wu L; Zhao X; Mao H; Xing C
Mol Med Rep; 2017 Nov; 16(5):6208-6213. PubMed ID: 28849074
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
13. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Hasan DM; Starke RM; Gu H; Wilson K; Chu Y; Chalouhi N; Heistad DD; Faraci FM; Sigmund CD
Hypertension; 2015 Jul; 66(1):211-20. PubMed ID: 25916724
[TBL] [Abstract][Full Text] [Related]
14. L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression.
Liang YJ; Jian JH; Chen CY; Hsu CY; Shih CY; Leu JG
Eur J Pharmacol; 2013 Sep; 715(1-3):33-8. PubMed ID: 23831394
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
16. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes.
Chen C; Ma C; Zhang Y; Zeng Y; Li Y; Wang W
Pharmacology; 2014; 94(5-6):265-72. PubMed ID: 25471680
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats.
Yuan X; Zhang Z; Gong K; Zhao P; Qin J; Liu N
Biol Pharm Bull; 2011; 34(5):618-23. PubMed ID: 21532147
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 shields vascular smooth muscle cells from oxidative stress.
Lovren F; Pan Y; Quan A; Singh KK; Khan R; Gupta N; Brezden-Masley C; Teoh H; Wheatcroft MD; Al-Omran M; Verma S
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1946-55, 1955.e1. PubMed ID: 24239235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
